Skip to search formSkip to main contentSkip to account menu

Conivaptan hydrochloride

Known as: (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride, CONIVAPTAN HCL 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Vaprisol

Broader (1)

conivaptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effects of conivaptan and mannitol on serum cytokine levels (TNF-α, IL-15 and IL-35) following bilateral carotid artery occlusion
Bu calismada, deneysel serebral iskemi-reperfuzyon hayvan modelinde akuaretik Conivaptan ve diuretik Mannitol tedavilerinin serum… 
2014
2014
Drug combination containing conivaptan hydrochloride as active ingredient and preparation of drug combination
The invention belongs to the technical field of medicine and discloses a drug combination containing conivaptan hydrochloride as… 
2009
2009
ASTELLAS LAUNCHES VAPRISOL ® (CONIVAPTAN HYDROCHLORIDE INJECTION) PREMIXED IN 5% DEXTROSE FOR THE TREATMENT OF HYPONATREMIA Arginine vasopressin (AVP) receptor antagonist now available in new…
DEERFIELD, Illinois, April 1, 2009 — Astellas Pharma US, Inc. today announced the commercial availability of Vaprisol (conivaptan… 
2008
2008
FDA APPROVES ASTELLAS' VAPRISOL ® (CONIVAPTAN HYDROCHLORIDE INJECTION) PREMIXED IN 5% DEXTROSE FOR THE TREATMENT OF HYPONATREMIA Arginine vasopressin (AVP) receptor antagonist now approved in single…
DEERFIELD, Illinois, October 22, 2008 — Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA… 
Review
2007
Review
2007
Conivaptan: new treatment for hyponatremia.
PURPOSE The pharmacology, bioavailability and pharmacokinetics, clinical efficacy, adverse effects and toxicities, drug… 
Review
2007
Review
2007
Current issues for nurse practitioners: Hyponatremia
Purpose: To review the assessment, diagnosis, and management of hyponatremia (serum sodium <135 mEq/L), the most common… 
2006
2006
New drugs: rasagiline mesylate, conivaptan hydrochloride, and sunitinib malate.
2006
2006
Molecule of the Month: Conivaptan hydrochloride.
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2000
2000
Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de…
Arginine vasopressin (AVP) has a dual action mainly in the periphery, i.e., vasoconstriction and water reabsorption via V1A and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)